Helping patients select long-acting reversible contraceptives.

To reduce the rate of unintended pregnancies, patients should select a contraceptive option that fits their needs and lifestyle. Long-acting reversible contraceptives (LARCs) are a relatively safe and effective option. This article outlines the characteristics of available LARCs and identifies the appropriate method for specific patient populations.

• Publication year

  2019

• Venue

  JAAPA : official journal of the American Academy of Physician Assistants

• Publication date

  2019-03-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.JAA.0000554220.48629.a4PMID 30913144
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.

  2018cited by this paper
• Long‐acting reversible contraception in adolescents: a systematic review and meta‐analysis

  2017cited by this paper
• Use of intrauterine devices in nulliparous women.

  2017cited by this paper
• Long-Acting Reversible Contraception for Adolescents: A Review

  2017cited by this paper
• Long‐acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short‐acting methods: a randomized patient preference trial

  2017cited by this paper
• Long‐Acting Reversible Contraception

  2017cited by this paper
• Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC).

  2016cited by this paper
• The safety of intrauterine devices in breastfeeding women: a systematic review.

  2016cited by this paper
• A Lower-Cost Option for Intrauterine Contraception.

  2016cited by this paper
• Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study

  2016cited by this paper
• Improving family planning with the use of long-acting reversible contraception use.

  2016cited by this paper
• Declines in Unintended Pregnancy in the United States, 2008-2011.

  2016cited by this paper
• Return of Spontaneous Menses and Fertility After Removal of the Liletta Levonorgestrel Intrauterine System [4O]

  2016cited by this paper
• Ultrasonography of intrauterine devices

  2015cited by this paper
• Increasing Use of Long-Acting Reversible Contraception to Decrease Unplanned Pregnancy.

  2015cited by this paper
• Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial.

  2015cited by this paper
• New Addition to Long-Acting Reversible Contraception

  2015cited by this paper
• Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.

  2015cited by this paper
• Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review.

  2015cited by this paper
• Contraception for Adolescents

  2014cited by this paper
• Intrauterine devices: an update.

  2014cited by this paper
• Contraceptive implants: current perspectives

  2014cited by this paper
• Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.

  2014cited by this paper
• Role of uterine forces in intrauterine device embedment, perforation, and expulsion

  2014cited by this paper
• Intrauterine devices & infection: Review of the literature

  2014cited by this paper
• Emergency Contraception Review: Evidence-based Recommendations for Clinicians

  2014cited by this paper
• Sexual and reproductive health care: a position paper of the Society for Adolescent Health and Medicine.

  2014cited by this paper
• Evaluation and treatment of endometriosis.

  2013cited by this paper
• Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.

  2013cited by this paper
• A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena.

  2012cited by this paper
• Preventing Unintended Pregnancies by Providing No-Cost Contraception

  2012cited by this paper
• Determinants of intrauterine contraception provision among US family physicians: a national survey of knowledge, attitudes and practice.

  2011cited by this paper
• Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women.

  2010cited by this paper
• Nexplanon®: what Implanon® did next

  2010cited by this paper
• Operative management of intrauterine device complications: a case series report.

  2010cited by this paper
• ACOG Committee Opinion no. 450: Increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy.

  2009cited by this paper
• Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system

  2008cited by this paper
• Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants.

  2006cited by this paper
• Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.

  2006cited by this paper
• Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen.

  2006cited by this paper
• TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age.

  2005cited by this paper
• The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up

  2005cited by this paper
• The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up.

  2005cited by this paper
• Pregnancy during the use of levonorgestrel intrauterine system.

  2004cited by this paper
• Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects.

  2002cited by this paper
• Ectopic pregnancy risk when contraception fails. A review.

  2002cited by this paper
• Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.

  1997cited by this paper
• IUD use and the risk of ectopic pregnancy: a meta-analysis of case-control studies.

  1995cited by this paper
• Intrauterine contraceptive device and pelvic inflammatory disease.

  1993cited by this paper
• Intrauterine devices and pelvic inflammatory disease: An international perspective

  1992cited by this paper
• American College of Obstetricians and Gynecologists

  1979cited by this paper
• [Which stage of the menstrual cycle in best suited for the insertion of IUD?].

  1978cited by this paper

• Effective patient education techniques for preventing unintended pregnancies.

  2019cites this paper